These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

188 related articles for article (PubMed ID: 28666608)

  • 1. Strict adherence rules to obtain monoclonal therapy might cost lives.
    Green RH; Shaw D
    Lancet Respir Med; 2017 Sep; 5(9):678-679. PubMed ID: 28666608
    [No Abstract]   [Full Text] [Related]  

  • 2. Pediatric asthma: guidelines-based care, omalizumab, and other potential biologic agents.
    Huffaker MF; Phipatanakul W
    Immunol Allergy Clin North Am; 2015 Feb; 35(1):129-44. PubMed ID: 25459581
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Improving Asthma Outcomes: Strategies for the Future.
    Lim TK
    Ann Acad Med Singap; 2016 Dec; 45(12):532-533. PubMed ID: 28062880
    [No Abstract]   [Full Text] [Related]  

  • 4. Adherence to inhaled corticosteroids and clinical outcomes following a year of benralizumab therapy for severe eosinophilic asthma.
    d'Ancona G; Kavanagh JE; Dhariwal J; Hearn AP; Roxas C; Fernandes M; Green L; Thomson L; Nanzer AM; Jackson DJ; Kent BD
    Allergy; 2021 Jul; 76(7):2238-2241. PubMed ID: 33432682
    [No Abstract]   [Full Text] [Related]  

  • 5. Reslizumab as add-on therapy in patients with refractory asthma.
    Virchow JC; McDonald M; Garin M; Korn S
    BMJ Open Respir Res; 2020 Apr; 7(1):. PubMed ID: 32273395
    [No Abstract]   [Full Text] [Related]  

  • 6. [PROPER USE OF INHALED CORTICOSTEROIDS IN ADULT PATIENTS WITH ASTHMA].
    Niimi A
    Arerugi; 2016; 65(6):757-63. PubMed ID: 27439578
    [No Abstract]   [Full Text] [Related]  

  • 7. [Asthma control: from myth to reality].
    Pacheco-Galván A
    Arch Bronconeumol; 2009 Jun; 45(6):306-7. PubMed ID: 19328611
    [No Abstract]   [Full Text] [Related]  

  • 8. Identifying the relationship between beliefs and medication adherence in asthma.
    Foot H; La Caze A; Cottrell N
    Ann Allergy Asthma Immunol; 2017 Sep; 119(3):284-285. PubMed ID: 28743425
    [No Abstract]   [Full Text] [Related]  

  • 9. New developments in the treatment of asthma.
    Douglas G
    Practitioner; 2007 Nov; 251(1700):30, 33-6. PubMed ID: 18087983
    [No Abstract]   [Full Text] [Related]  

  • 10. A tailored mobile health intervention to improve adherence and asthma control in minority adolescents.
    Mosnaim G; Li H; Martin M; Richardson D; Belice PJ; Avery E; Silberstein A; Leigh J; Kenyon R; Jones S; Bender B; Powell LH
    J Allergy Clin Immunol Pract; 2015; 3(2):288-290.e1. PubMed ID: 25609351
    [No Abstract]   [Full Text] [Related]  

  • 11. Fostering adherence to optimize therapy in asthma.
    Xin JB; Shi HZ
    Chin Med J (Engl); 2010 Jan; 123(1):3-5. PubMed ID: 20137566
    [No Abstract]   [Full Text] [Related]  

  • 12. Assessing the value of mepolizumab for severe eosinophilic asthma: a cost-effectiveness analysis.
    Whittington MD; McQueen RB; Ollendorf DA; Tice JA; Chapman RH; Pearson SD; Campbell JD
    Ann Allergy Asthma Immunol; 2017 Feb; 118(2):220-225. PubMed ID: 27923549
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Early pharmacological intervention in mild pediatric asthma--background and definitions.
    Pedersen S
    Pediatr Allergy Immunol; 2006 May; 17 Suppl 17():5-6. PubMed ID: 16573702
    [No Abstract]   [Full Text] [Related]  

  • 14. Characterisation of an OCS-dependent severe asthma population treated with mepolizumab.
    Prazma CM; Wenzel S; Barnes N; Douglass JA; Hartley BF; Ortega H
    Thorax; 2014 Dec; 69(12):1141-2. PubMed ID: 24834924
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Nearly uncontrollable hyperreactivity. Last options in bronchial asthma].
    Füesl HS; Stiefelhagen P
    MMW Fortschr Med; 2014 Mar; 156(5):17. PubMed ID: 24912253
    [No Abstract]   [Full Text] [Related]  

  • 16. Unmet needs in the pharmacological treatment of asthma.
    Bousquet J; Demoly P; Chanez P; Godard P
    Pulm Pharmacol Ther; 1999; 12(2):63-5. PubMed ID: 10373382
    [No Abstract]   [Full Text] [Related]  

  • 17. Asthma in 2016: reassured about the old, excited about the new.
    Sood S; Castro M
    Lancet Respir Med; 2016 Dec; 4(12):937-939. PubMed ID: 27890498
    [No Abstract]   [Full Text] [Related]  

  • 18. Older women with severe asthma are not making the best use of recommended medications.
    Rollins G
    Rep Med Guidel Outcomes Res; 2002 Sep; 13(17):5-7. PubMed ID: 12572546
    [No Abstract]   [Full Text] [Related]  

  • 19. Adherence to asthma medication: a question of ability?
    Horne R
    Prim Care Respir J; 2011 Jun; 20(2):118-9. PubMed ID: 21597663
    [No Abstract]   [Full Text] [Related]  

  • 20. Biological treatment is approved for severe eosinophilic asthma.
    Mayor S
    BMJ; 2016 Nov; 355():i6472. PubMed ID: 27908911
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 10.